Búsqueda | Portal de Búsqueda de la BVS Colombia

1.

Correction to: Geography of Fracture Incidence in Postmenopausal Women with Osteoporosis Treated with Abaloparatide.

McClung, Michael R; Williams, Gregory C; Hattersley, Gary; Fitzpatrick, Lorraine A; Wang, Yamei; Miller, Paul D.

Calcif Tissue Int ; 102(6): 634, 2018 06.

Artículo en Inglés | MEDLINE | ID: mdl-29383409

2.

Geography of Fracture Incidence in Postmenopausal Women with Osteoporosis Treated with Abaloparatide.

McClung, Michael R; Williams, Gregory C; Hattersley, Gary; Fitzpatrick, Lorraine A; Wang, Yamei; Miller, Paul D.

Calcif Tissue Int ; 102(6): 627-633, 2018 06.

Artículo en Inglés | MEDLINE | ID: mdl-29285549

3.

Abaloparatide is an Effective Treatment Option for Postmenopausal Osteoporosis: Review of the Number Needed to Treat Compared with Teriparatide.

Reginster, Jean-Yves; Hattersley, Gary; Williams, Gregory C; Hu, Ming-Yi; Fitzpatrick, Lorraine A; Lewiecki, E Michael.

Calcif Tissue Int ; 103(5): 540-545, 2018 11.

Artículo en Inglés | MEDLINE | ID: mdl-29951742

4.

A Challenging Case of Tumor-Induced Osteomalacia: Pathophysiological and Clinical Implications.

Colangelo, Luciano; Cipriani, Cristiana; Pepe, Jessica; Corsi, Alessandro; Sonato, Chiara; Follacchio, Giulia; Cilli, Mirella; Gianni, Walter; Ferrone, Federica; Moreschini, Oreste; Fitzpatrick, Lorraine A; Minisola, Salvatore.

Calcif Tissue Int ; 103(4): 465-468, 2018 10.

Artículo en Inglés | MEDLINE | ID: mdl-29736882

5.

Evaluation of Quantitative Computed Tomography Cortical Hip Quadrant in a Clinical Trial With Rosiglitazone: A Potential New Study Endpoint.

Miller, Colin G; Bogado, Cesar C; Nino, Antonio J; Northcutt, Allison R; Yu, Hui Jing; Lewiecki, E Michael; Paul, G; Cobitz, Alexander R; Wooddell, Margaret J; Bilezikian, John P; Fitzpatrick, Lorraine A.

J Clin Densitom ; 19(4): 485-491, 2016 10.

Artículo en Inglés | MEDLINE | ID: mdl-27052635

6.

Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial.

Miller, Paul D; Hattersley, Gary; Riis, Bente Juel; Williams, Gregory C; Lau, Edith; Russo, Luis Augusto; Alexandersen, Peter; Zerbini, Cristiano A F; Hu, Ming-yi; Harris, Alan G; Fitzpatrick, Lorraine A; Cosman, Felicia; Christiansen, Claus.

JAMA ; 316(7): 722-33, 2016 Aug 16.

Artículo en Inglés | MEDLINE | ID: mdl-27533157

7.

Erratum for Abaloparatide in Postmenopausal Women With Osteoporosis and Type 2 Diabetes: A Post Hoc Analysis of the ACTIVE Study.

Dhaliwal, Ruban; Hans, Didier; Hattersley, Gary; Mitlak, Bruce; Fitzpatrick, Lorraine A; Wang, Yamei; Schwartz, Ann V; Miller, Paul D; Josse, Robert G.

JBMR Plus ; 5(2): e10414, 2021 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-33615100

8.

Abaloparatide: an anabolic treatment to reduce fracture risk in postmenopausal women with osteoporosis.

Miller, Paul D; Bilezikian, John P; Fitzpatrick, Lorraine A; Mitlak, Bruce; McCloskey, Eugene V; Cosman, Felicia; Bone, Henry G.

Curr Med Res Opin ; 36(11): 1861-1872, 2020 11.

Artículo en Inglés | MEDLINE | ID: mdl-32969719

9.

Abaloparatide followed by alendronate in women ≥80 years with osteoporosis: post hoc analysis of ACTIVExtend.

Greenspan, Susan L; Fitzpatrick, Lorraine A; Mitlak, Bruce; Wang, Yamei; Harvey, Nicholas C; Deal, Chad; Cosman, Felicia; McClung, Michael.

Menopause ; 27(10): 1137-1142, 2020 10.

Artículo en Inglés | MEDLINE | ID: mdl-32665529

10.

Cost-effectiveness of sequential treatment with abaloparatide followed by alendronate vs. alendronate monotherapy in women at increased risk of fracture: A US payer perspective.

Hiligsmann, Mickael; Williams, Setareh A; Fitzpatrick, Lorraine A; Silverman, Stuart S; Weiss, Richard; Reginster, Jean-Yves.

Semin Arthritis Rheum ; 50(3): 394-400, 2020 06.

Artículo en Inglés | MEDLINE | ID: mdl-32160943

11.

Abaloparatide in Postmenopausal Women With Osteoporosis and Type 2 Diabetes: A Post Hoc Analysis of the ACTIVE Study.

Dhaliwal, Ruban; Hans, Didier; Hattersley, Gary; Mitlak, Bruce; Fitzpatrick, Lorraine A; Wang, Yamei; Schwartz, Ann V; Miller, Paul D; Josse, Robert G.

JBMR Plus ; 4(4): e10346, 2020 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-32258965

12.

Once-monthly oral ibandronate improves biomechanical determinants of bone strength in women with postmenopausal osteoporosis.

Lewiecki, E Michael; Keaveny, Tony M; Kopperdahl, David L; Genant, Harry K; Engelke, Klaus; Fuerst, Thomas; Kivitz, Alan; Davies, Richard Y; Fitzpatrick, Lorraine A.

J Clin Endocrinol Metab ; 94(1): 171-80, 2009 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-18840641

13.

Response rates for hip, femoral neck, and lumbar spine bone mineral density in patients treated with abaloparatide followed by alendronate: Results from phase 3 ACTIVExtend.

Deal, Chad L; Mitlak, Bruce H; Wang, Yamei; Fitzpatrick, Lorraine A; Miller, Paul D.

Bone Rep ; 11: 100230, 2019 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-31799340

14.

Cost-effectiveness of sequential treatment with abaloparatide vs. teriparatide for United States women at increased risk of fracture.

Hiligsmann, Mickael; Williams, Setareh A; Fitzpatrick, Lorraine A; Silverman, Stuart S; Weiss, Richard; Reginster, Jean-Yves.

Semin Arthritis Rheum ; 49(2): 184-196, 2019 10.

Artículo en Inglés | MEDLINE | ID: mdl-30737062

15.

Abaloparatide in patients with mild or moderate renal impairment: results from the ACTIVE phase 3 trial.

Bilezikian, John P; Hattersley, Gary; Mitlak, Bruce H; Hu, Ming-Yi; Fitzpatrick, Lorraine A; Dabrowski, Christine; Miller, Paul D; Papapoulos, Socrates E.

Curr Med Res Opin ; 35(12): 2097-2102, 2019 12.

Artículo en Inglés | MEDLINE | ID: mdl-31418585

16.

Molecular, endocrine, and genetic mechanisms of arterial calcification.

Doherty, Terence M; Fitzpatrick, Lorraine A; Inoue, Daisuke; Qiao, Jian-Hua; Fishbein, Michael C; Detrano, Robert C; Shah, Prediman K; Rajavashisth, Tripathi B.

Endocr Rev ; 25(4): 629-72, 2004 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-15294885

17.

Soy isoflavones: hope or hype?

Fitzpatrick, Lorraine A.

Maturitas ; 61(1-2): 132-40, 2008.

Artículo en Inglés | MEDLINE | ID: mdl-19434885

18.

Parathyroid hormone and the cardiovascular system.

Fitzpatrick, Lorraine A; Bilezikian, John P; Silverberg, Shonni J.

Curr Osteoporos Rep ; 6(2): 77-83, 2008 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-18778568

19.

Effects of abaloparatide on bone mineral density and risk of fracture in postmenopausal women aged 80 years or older with osteoporosis.

McClung, Michael R; Harvey, Nicholas C; Fitzpatrick, Lorraine A; Miller, Paul D; Hattersley, Gary; Wang, Yamei; Cosman, Felicia.

Menopause ; 25(7): 767-771, 2018 07.

Artículo en Inglés | MEDLINE | ID: mdl-29462094

20.

ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis.

Bone, Henry G; Cosman, Felicia; Miller, Paul D; Williams, Gregory C; Hattersley, Gary; Hu, Ming-Yi; Fitzpatrick, Lorraine A; Mitlak, Bruce; Papapoulos, Socrates; Rizzoli, René; Dore, Robin K; Bilezikian, John P; Saag, Kenneth G.

J Clin Endocrinol Metab ; 103(8): 2949-2957, 2018 08 01.

Artículo en Inglés | MEDLINE | ID: mdl-29800372

Portal de Búsqueda de la BVS Colombia

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: